A detailed history of Geneos Wealth Management Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 1,324 shares of MRNA stock, worth $87,053. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,324
Previous 1,324 -0.0%
Holding current value
$87,053
Previous $141,000 11.35%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

SELL
$85.37 - $115.44 $33,721 - $45,598
-395 Reduced 22.98%
1,324 $141,000
Q4 2023

Jan 26, 2024

SELL
$69.51 - $104.43 $19,740 - $29,658
-284 Reduced 14.18%
1,719 $170,000
Q3 2023

Oct 11, 2023

BUY
$96.41 - $126.61 $41,649 - $54,695
432 Added 27.5%
2,003 $206,000
Q2 2023

Aug 08, 2023

BUY
$118.5 - $160.53 $5,925 - $8,026
50 Added 3.29%
1,571 $190,000
Q1 2023

Apr 25, 2023

SELL
$135.66 - $197.02 $6,783 - $9,851
-50 Reduced 3.18%
1,521 $233,000
Q4 2022

Jan 30, 2023

SELL
$118.38 - $210.04 $52,560 - $93,257
-444 Reduced 22.03%
1,571 $282,000
Q3 2022

Nov 14, 2022

SELL
$118.07 - $194.18 $374,872 - $616,521
-3,175 Reduced 61.18%
2,015 $238,000
Q2 2022

Jul 22, 2022

SELL
$117.13 - $176.59 $585 - $882
-5 Reduced 0.1%
5,190 $741,000
Q1 2022

May 16, 2022

BUY
$126.46 - $235.05 $2,023 - $3,760
16 Added 0.31%
5,195 $894,000
Q4 2021

Feb 09, 2022

BUY
$225.82 - $368.51 $37,486 - $61,172
166 Added 3.31%
5,179 $1.32 Million
Q2 2021

Jul 08, 2021

SELL
$129.91 - $234.98 $60,667 - $109,735
-467 Reduced 8.52%
5,013 $1.17 Million
Q1 2021

Jun 17, 2021

SELL
$109.18 - $185.98 $169,229 - $288,269
-1,550 Reduced 22.05%
5,480 $988,000
Q4 2020

May 19, 2021

BUY
$65.74 - $169.86 $181,376 - $468,643
2,759 Added 64.6%
7,030 $863,000
Q3 2020

Sep 07, 2021

BUY
$54.34 - $94.85 $23,420 - $40,880
431 Added 11.22%
4,271 $296,000
Q2 2020

Sep 07, 2021

BUY
$29.67 - $80.0 $35,811 - $96,560
1,207 Added 45.84%
3,840 $235,000
Q1 2020

Sep 07, 2021

BUY
$17.78 - $31.58 $46,814 - $83,150
2,633 New
2,633 $79,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Geneos Wealth Management Inc. Portfolio

Follow Geneos Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.